amlexanox has been researched along with Neoplasms in 2 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Excerpt | Relevance | Reference |
---|---|---|
"Amlexanox (AMX) is an azoxanthone drug used for decades for the treatment of mouth aphthous ulcers and now considered for the treatment of diabetes and obesity." | 2.82 | The potential value of amlexanox in the treatment of cancer: Molecular targets and therapeutic perspectives. ( Bailly, C, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bailly, C | 1 |
Guo, Y | 1 |
Jin, S | 1 |
Song, D | 1 |
Yang, T | 1 |
Hu, J | 1 |
Hu, X | 1 |
Han, Q | 1 |
Zhao, J | 1 |
Guo, Z | 1 |
Wang, X | 1 |
1 review available for amlexanox and Neoplasms
Article | Year |
---|---|
The potential value of amlexanox in the treatment of cancer: Molecular targets and therapeutic perspectives.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Drug Delivery Systems; Humans; Neoplasms; Treatment | 2022 |
1 other study available for amlexanox and Neoplasms
Article | Year |
---|---|
Amlexanox-modified platinum(IV) complex triggers apoptotic and autophagic bimodal death of cancer cells.
Topics: Aminopyridines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; bcl-2-As | 2022 |